This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a McGill University directory, so their courses may be missing. Find their university profile.
Research
Latest papers
Sex-specific alterations in pulmonary metabolic, xenobiotic and lipid signalling pathways after e-cigarette aerosol exposure during adolescence in mice.
BMJ open respiratory research · 2024 · senior author
Increased sensitivity to chemically induced colitis in mice harboring a DNA-binding deficient aryl hydrocarbon receptor.
Toxicological sciences : an official journal of the Society of Toxicology · 2023
Chronic aryl hydrocarbon receptor activity phenocopies smoking-induced skeletal muscle impairment.
Journal of cachexia, sarcopenia and muscle · 2022
Latest funding
- $67,500
Does E-cigarette Use Enhance Lung Tumor Formation?
CIHR · 2025 · Co-investigator
- $120,000
Exploring the cardiometabolic consequences of vaping
CIHR · 2025 · Supervisor
- $994,500
Wildfire smoke inhibition of CFTR: mechanisms and mitigation
CIHR · 2024 · Co-investigator
3 publications.
Sex-specific alterations in pulmonary metabolic, xenobiotic and lipid signalling pathways after e-cigarette aerosol exposure during adolescence in mice.
Paoli S, Eidelman DH, Mann KK, Baglole C
Increased sensitivity to chemically induced colitis in mice harboring a DNA-binding deficient aryl hydrocarbon receptor.
Alvik K, Shao P, Hutin D, Baglole C, Grant DM, Matthews J
Chronic aryl hydrocarbon receptor activity phenocopies smoking-induced skeletal muscle impairment.
Thome T, Miguez K, Willms AJ, Burke SK, Chandran V, de Souza AR, Fitzgerald LF, Baglole C, Anagnostou ME, Bourbeau J, Jagoe RT, Morais JA, Goddard Y, Taivassalo T, Ryan TE, Hepple RT
Does E-cigarette Use Enhance Lung Tumor Formation?
Principal investigators: Mann, Koren K
Keywords: Cancer
Exploring the cardiometabolic consequences of vaping
Principal investigators: Caruana, Vincenza
Keywords: Aav-Pcsk9; Atherosclerosis; Cardiovascular; Dyslipidemia; E-Cigarette; Hepatic Dysregulation; Metabolism; Omics; Sex-Specific; Vaping
Wildfire smoke inhibition of CFTR: mechanisms and mitigation
Principal investigators: Hanrahan, John W
Keywords: Acquired Cftr Deficiency; Cftr (Cystic Fibrosis Transmembrane Conductance Regulator); Copd Exacerbations; Redox Balance; Wildfire Smoke
PPAR Signaling Disruption by Cannabis Products Impairs Respiratory Defense Mechanisms
Principal investigators: Arlen, Maddison T
Keywords: Cannabis; Cre-Lox Recombination; Exposure; Influenza; Innate Immunity; Lung Epithelium; Metabolomics; Ppar Signalling; Smoking; Vaping
Development of Preclinical Inhalation Model to Test Vaporized Cannabis Distillates
Principal investigators: Gorgani, Roham
Keywords: Respiratory; Vaporized Cannabis Distillate Products
Immunophenotypic di¿erences in the pulmonary response of BALB/c and C57BL/6 mice to e-cigarette aerosols
Principal investigators: Paoli, Sofia
Keywords: E-Cigarette; Mice; Pulmonary Response
Ahr Controls Pulmonary Inflammation from Cannabis Smoke
Principal investigators: Wilson, Emily T
Keywords: Cannabis; Pulmonary Inflammation; Thc
Decoding how the aryl hydrocarbon receptor (AhR) controls cigarette smoke-induced lung inflammation and development of chronic obstructive pulmonary disease (COPD)
Principal investigators: Baglole, Carolyn
Keywords: Aryl Hydrocarbon Receptor; Chronic Obstructive Pulmonary Disease; Cigarette Smoke; Inflammation
Smoke effects on cell function and role in COPD
Principal investigators: Hanrahan, John W
Keywords: Acquired Cftr Deficiency; Cftr (Cystic Fibrosis Transmembrane Conductance Regulator); Copd; Redox Balance; Smoke
Unagi: Computational approach driven repurposed drugs for idiopathic pulmonary fibrosis
Principal investigators: Ding, Jun
Keywords: Cellular Dynamics; Cmap; Drug Repurposing; Graphical Models; Idiopathic Pulmonary Fibrosis; In-Silico; Machine Learning; Perturbation; Single Cell; Time-Series
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Medicine
- Pharmacology and Toxicology
Co-authors at McGill University, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.